Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:PTLA
Date5/2013
Raised$100M
Post IPO Valuation

General Information

Offices

South San Francisco, USA
270 E. Grand Avenue
South San Francisco, CA, 94080
USA

People

CEO
Chairman of the Board
CFO
Board of Directors
Board of Directors
Board Member
Executive Vice President, Research and Development

Funding

TOTAL $158M
FUNDING TOTAL $158M
Series C, 6/2009
$60.1M
Series D, 11/2011
Temasek Holdings
Eastern Capital
$89M
Private Equity, 12/2011
$9M

Tags

Portola Pharmaceuticals

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company’s products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. Its products also include PRT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company’s products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. Portola Pharmaceuticals, Inc. was founded in 2003 and is based in South San Francisco, California.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. Portola Pharmaceuticals Announces Completion of $89 Million Financing (portola.com) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 2/27/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy